Paclitaxel

Common brands: Abraxane, Paclitaxel Paclitaxel, Paclitaxel Protein Bound Particles Albumin Bound, Paclitaxel Protein-Bound Particles For Injectable Suspension (Albumin-Bound), Carboplatin

Top reporter: Abraxis Bioscience, Llc

Microtubule Inhibitor [EPC]Platinum-based Drug [EPC]Programmed Death Receptor-1 Blocking Antibody [EPC]Vascular Endothelial Growth Factor Inhibitor [EPC]HER2/neu Receptor Antagonist [EPC]
95,861
Total Reports
50,663
Serious Reports
15,996
Death Reports
30
Reported Reactions
Death Report Ratio: High (16.69%)

Patient Demographics

Male
24,537
Female
58,698

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Paclitaxel.

# Reaction Reports % of Total
1 NAUSEA 5,397
5.5%
2 NEUTROPENIA 5,327
5.5%
3 DIARRHOEA 5,062
5.2%
4 DYSPNOEA 5,035
5.2%
5 OFF LABEL USE 5,029
5.1%
6 ANAEMIA 4,707
4.8%
7 DEATH 4,403
4.5%
8 MALIGNANT NEOPLASM PROGRESSION 4,159
4.3%
9 FATIGUE 4,133
4.2%
10 PYREXIA 3,840
3.9%
11 NEUROPATHY PERIPHERAL 3,831
3.9%
12 DISEASE PROGRESSION 3,792
3.9%
13 VOMITING 3,746
3.8%
14 FEBRILE NEUTROPENIA 3,630
3.7%
15 MYELOSUPPRESSION 3,280
3.4%
16 THROMBOCYTOPENIA 2,978
3.0%
17 ASTHENIA 2,875
2.9%
18 DRUG INEFFECTIVE 2,665
2.7%
19 RASH 2,398
2.5%
20 DECREASED APPETITE 2,300
2.4%
21 PNEUMONIA 2,165
2.2%
22 ERYTHEMA 2,100
2.1%
23 ABDOMINAL PAIN 1,978
2.0%
24 NEUTROPHIL COUNT DECREASED 1,964
2.0%
25 LEUKOPENIA 1,938
2.0%
26 HYPERTENSION 1,922
2.0%
27 ALOPECIA 1,841
1.9%
28 WHITE BLOOD CELL COUNT DECREASED 1,806
1.8%
29 GENERAL PHYSICAL HEALTH DETERIORATION 1,738
1.8%
30 BACK PAIN 1,682
1.7%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.